Skip to main content
Equibles

Mariner, LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1373442 Overland Park, KS
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16,086
-$3,686 QoQ
Shares Held
12,280
-1.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 130 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Mariner, LLC holds $491,869,472 across 152 Biotechnology names. LCTX ranks #149 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JAZZ
Jazz Pharmaceuticals plc
 608,615 $146,657,956
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 134,614 $66,866,811
3 REGN
Regeneron Pharmaceuticals, Inc.
 100,086 $62,407,624
4 RPRX
Royalty Pharma plc
 693,495 $38,884,263
5 EXEL
Exelixis, Inc.
 313,083 $17,034,845
6 INCY
Incyte Corp
 121,988 $13,828,559
7 BMRN
Biomarin Pharmaceutical Inc
 192,607 $11,020,972
8 ALNY
Alnylam Pharmaceuticals, Inc.
 28,021 $8,435,161

All Filings in LCTX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,086 12,280
2026-03-31 $19,772 12,514
2025-12-31 $21,873 13,098
2025-09-30 $18,919 11,195
2025-06-30 $11,805 12,973
2025-03-31 $6,406 14,236
2024-12-31 $7,421 14,842
2024-09-30 $13,504 14,840
2024-06-30 $14,840 14,840
2024-03-31 $24,923 16,840
2023-12-31 $16,175 14,840
2023-09-30 $37,762 32,002
2023-06-30 $45,083 31,974
2023-03-31 $20,760 13,840
2022-12-31 $16,244 13,884
2022-09-30 $16,076 14,227